Aneuploidy Enables Cross-Adaptation to Unrelated Drugs
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Aneuploidy is common both in tumor cells responding to chemotherapeutic agents and in fungal cells adapting to antifungal drugs. Because aneuploidy simultaneously affects many genes, it has the potential to confer multiple phenotypes to the same cells. Here, we analyzed the mechanisms by which Candida albicans, the most prevalent human fungal pathogen, acquires the ability to survive both chemotherapeutic agents and antifungal drugs. Strikingly, adaptation to both types of drugs was accompanied by the acquisition of specific whole-chromosome aneuploidies, with some aneuploid karyotypes recovered independently and repeatedly from very different drug conditions. Specifically, strains selected for survival in hydroxyurea, an anticancer drug, acquired cross-adaptation to caspofungin, a first-line antifungal drug, and both acquired traits were attributable to trisomy of the same chromosome: loss of trisomy was accompanied by loss of adaptation to both drugs. Mechanistically, aneuploidy simultaneously altered the copy number of most genes on chromosome 2, yet survival in hydroxyurea or caspofungin required different genes and stress response pathways. Similarly, chromosome 5 monosomy conferred increased tolerance to both fluconazole and to caspofungin, antifungals with different mechanisms of action. Thus, the potential for cross-adaptation is not a feature of aneuploidy per se; rather, it is dependent on specific genes harbored on given aneuploid chromosomes. Furthermore, pre-exposure to hydroxyurea increased the frequency of appearance of caspofungin survivors, and hydroxyurea-adapted C. albicans cells were refractory to antifungal drug treatment in a mouse model of systemic candidiasis. This highlights the potential clinical consequences for the management of cancer chemotherapy patients at risk of fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Fig. 7. Effect of HU pre-exposure on cross-adaptation to caspofungin. Parental strain SC5314 was passaged daily for 7 days in YPD+HU (IC50; 2.814 mg/ml) at 37 °C, washed, and growth was measured on either solid (A) or liquid (B) medium. (A) ∼1 × 105 cells were plated on YPD plates (with or without CSP [100 ng/ml] as indicated) and incubated at 37 °C for 3 days. (B) Passaged cells (with or without HU from the pre-exposure period above) were plated on YPD at a cell density of ∼200 CFUs/plate and incubated at 37 °C for 24 h. From each plate, 94 colonies from the control YPD treatment (gray curves), and 94 colonies from the YPD+HU treatment (blue curves) were randomly selected and grown at 37 °C in YPD with or without CSP (100 ng/ml); parental strain without pre-exposure was also tested (red curves). Growth was measured as absorbance at 600 nm every 15 min. (C) Strains evolved for 7 days as above were analyzed by spot assays. Serial dilutions of cell suspension were spotted (3 µl/spot) on YPD plates supplemented with the indicated concentrations of HU or CSP and incubated at 37 °C for 48 h. Each condition was tested a minimum of three independent times. Growth is represented in a heat map comparing strains with or without Chr2 trisomy (Chr2x3, euploid, respectively), as described in methods.](https://figures.cochat.ai/paper-figures/33dd5a021e3e44cabf27e77683ac988e/aneuploidy-enables-cross-adaptation-to-unrelated-drugs-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent work in C. albicans demonstrated that exposure to the cancer chemotherapeutic hydroxyurea, or the ER stress-inducing agent tunicamycin selects for trisomy of chromosome 2, which also enables tolerance to the echinocandin caspofungin66,67.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yang et al. found three negative regulators of echinocandin susceptibility on chr5. These are CHT2, encoding a glycosylphosphatidylinositol (GPI)-dependent chitinase, a covalently bound cell wall protein, PGA4, encoding a GPI-anchored cell surface 1,3-β-d-glucanosyltransferase, and CSU51 encoding another putative GPI-anchored protein [132].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [132]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Copy number variations, including whole-chromosome aneuploidy and shorter-range amplifications, are genome changes that can increase resistance32,43–49.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“C. albicans’ heteroresistance to echinocandins is related to chr2, as chr2 trisomy can be induced after exposure to caspofungin [132].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 1×
“The images were processed by a custom Fiji/ ImageJ plugin (Schindelin et al. 2012; Schneider et al. 2012).”
MethodNIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · cited 1×
“The images were processed by a custom Fiji/ ImageJ plugin (Schindelin et al. 2012; Schneider et al. 2012).”
MethodHidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · cited 1×
“A leading cause of such infections is Candida albicans, a common member of the commensal microbiome (Brown et al. 2012; Mousset et al. 2014; Lai et al. 2019).”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298 · cited 1×
“This also implies that cancer chemotherapy with HU has the potential to promote cross-adaptation to CSP. Relevance In Vivo CSP is a first-line antifungal drug used in clinics for the treatment of systemic candidiasis (Pappas et al. 2016).”
BackgroundGenome evolution across 1,011 Saccharomyces cerevisiae isolates
Peter, J., De Chiara, M., Friedrich, A., Yue, J.-X., Pflieger, D., Bergström, A., Sigwalt, A., Barre, B., Freel, K., Llored, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0030-5 · Cited by 1,117 · cited 1×
“albicans: wild and clinical isolates of the model yeast Saccharomyces cerevisiae often carry aneuploidies as well (Sunshine et al. 2015; Gallone et al. 2016; Gasch et al. 2016; Zhu et al. 2016; Peter et al. 2018).”
BackgroundEffects of Aneuploidy on Cellular Physiology and Cell Division in Haploid Yeast
Torres, E. M., Sokolsky, T., Tucker, C. M., Chan, L. Y., Boselli, M., Dunham, M. J., & Amon, A. (2007) · Science · doi:10.1126/science.1142210 · Cited by 935 · cited 1×
“Aneuploidies often incur a fitness cost, reducing adaptation to many growth conditions (Torres et al. 2007; Sheltzer and Amon 2011).”
Background
Research works printed but not linked: 1
- O'Neill J. 2016 Tackling drug-resistant infections globally: final report and recommendations. Available from: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf, last accessed March 5, 2019.
Cited by
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Self-citationd'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304
“Recent work in C. albicans demonstrated that exposure to the cancer chemotherapeutic hydroxyurea, or the ER stress-inducing agent tunicamycin selects for trisomy of chromosome 2, which also enables tolerance to the echinocandin caspofungin 66,67 .”
Candida albicans biofilms and polymicrobial interactions
Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843400 · Cited by 281
“…including constitutive expression and activation of drug efflux pumps, mutation of genes encoding drug targets, the acquisition of drug tolerance (Berman and Krysan 2020), alterations in the copy number of genes via aneuploidy (Yang et al. 2019) and adaptive mistranslation (Weil et al. 2017).”
BackgroundChromosomal instability accelerates the evolution of resistance to anti-cancer therapies
Lukow, D. A., Sausville, E. L., Suri, P., Chunduri, N. K., Wieland, A., Leu, J., Smith, J. C., Girish, V., Kumar, A. A., Kendall, J., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.07.009 · Cited by 228
The importance of antimicrobial resistance in medical mycology
Gow, N. A. R., Johnson, C., Berman, J., Coste, A. T., Cuomo, C. A., Perlin, D. S., Bicanic, T., Harrison, T. S., Wiederhold, N., Bromley, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32249-5 · Cited by 224
Self-citationIslam, T., Danishuddin, Tamanna, N. T., Matin, M. N., Barai, H. R., & Haque, M. A. (2024) · Plants · doi:10.3390/plants13192737 · Cited by 186
“Aneuploidy can confer resistance to medications unrelated to cross-tolerance by altering the copy number of numerous genes simultaneously [102].”
BackgroundCandida auris Genetics and Emergence
Chowdhary, A., Jain, K., & Chauhan, N. (2023) · Annual Review of Microbiology · doi:10.1146/annurev-micro-032521-015858 · Cited by 158
Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs
Todd, R. T., & Selmecki, A. (2020) · eLife · doi:10.7554/elife.58349 · Cited by 138
“albicans and other fungal pathogens (Forche et al., 2009; Forche et al., 2019; Gerstein et al., 2015; Janbon et al., 1998; Ngamskulrungroj et al., 2012; Poláková et al., 2009; Reedy et al., 2009; Rustchenko-Bulgac, 1991; Selmecki et al., 2006; Selmecki et al., 2009; Sionov et al., 2013; Yang et al., 2019).”
BackgroundPienta, K. J., Hammarlund, E. U., Brown, J. S., Amend, S. R., & Axelrod, R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020838118 · Cited by 105
Interspecific hybridization as a driver of fungal evolution and adaptation
Steensels, J., Gallone, B., & Verstrepen, K. J. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00537-4 · Cited by 109
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Murphy, S. E., & Bicanic, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759408 · Cited by 83
Chromosomal instability and aneuploidy as causes of cancer drug resistance
Lukow, D. A., & Sheltzer, J. M. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.002 · Cited by 89
Natural proteome diversity links aneuploidy tolerance to protein turnover
Muenzner, J., Trébulle, P., Agostini, F., Zauber, H., Messner, C. B., Steger, M., Kilian, C., Lau, K., Barthel, N., Lehmann, A., et al. (2024) · Nature · doi:10.1038/s41586-024-07442-9 · Cited by 81
Self-citationCancer cells employ an evolutionarily conserved polyploidization program to resist therapy
Pienta, K. J., Hammarlund, E. U., Austin, R. H., Axelrod, R., Brown, J. S., & Amend, S. R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.016 · Cited by 83
Poly‐aneuploid cancer cells promote evolvability, generating lethal cancer
Pienta, K. J., Hammarlund, E. U., Axelrod, R., Brown, J. S., & Amend, S. R. (2020) · Evolutionary Applications · doi:10.1111/eva.12929 · Cited by 78
“…and, perhaps most significantly, epigenetically access cellular programs typically restricted to subsets of tissue cell types, for example, macrophages, osteoclasts, and trophoblasts (Brooks et al., 2019; Diaz, Wood, Sibley, & Greenwood, 2014; Pereira et al., 2018; Yang et al., 2019).”
BackgroundThe fitness costs and benefits of trisomy of each Candida albicans chromosome
Yang, F., Todd, R. T., Selmecki, A., Jiang, Y.-Y., Cao, Y.-B., & Berman, J. (2021) · Genetics · doi:10.1093/genetics/iyab056 · Cited by 72
Self-citationEmergence and evolution of virulence in human pathogenic fungi
Siscar-Lewin, S., Hube, B., & Brunke, S. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.12.013 · Cited by 75
The Dynamic Fungal Genome: Polyploidy, Aneuploidy and Copy Number Variation in Response to Stress
Vande Zande, P., Zhou, X., & Selmecki, A. (2023) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041320-112443 · Cited by 70
“The upregulation of many genes simultaneously can result in adaptation to multiple stressors at once, such as in the evolution of multidrug resistance (141).”
BackgroundThe CRISPR toolbox in medical mycology: State of the art and perspectives
Morio, F., Lombardi, L., & Butler, G. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008201 · Cited by 68
“albicans, in which specific whole-chromosome aneuploidies have been associated with drug resistance and/or cross-adaptation to different drugs [73].”
BackgroundEvolutionary Dynamics of the Spindle Assembly Checkpoint in Eukaryotes
Kops, G. J. P. L., Snel, B., & Tromer, E. C. (2020) · Current Biology · doi:10.1016/j.cub.2020.02.021 · Cited by 73
Yang, F., Scopel, E. F. C., Li, H., Sun, L.-L., Kawar, N., Cao, Y.-B., Jiang, Y.-Y., & Berman, J. (2023) · mBio · doi:10.1128/mbio.00227-23 · Cited by 62
Self-citationA Double-Edged Sword: Aneuploidy is a Prevalent Strategy in Fungal Adaptation
Tsai, H.-J., & Nelliat, A. (2019) · Genes · doi:10.3390/genes10100787 · Cited by 60
“(2019) [76] Hydroxyurea resistance II (+1) Yang et al.”
BackgroundTunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans
Yang, F., Gritsenko, V., Slor Futterman, Y., Gao, L., Zhen, C., Lu, H., Jiang, Y.-Y., & Berman, J. (2021) · mBio · doi:10.1128/mbio.02272-21 · Cited by 59
“Earlier work (17) found that Chr2 trisomy promoted cross-adaptation to both CSP, a”
BackgroundSelf-citationCell Fusion-Mediated Tissue Regeneration as an Inducer of Polyploidy and Aneuploidy
Dörnen, J., Sieler, M., Weiler, J., Keil, S., & Dittmar, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051811 · Cited by 50
Yang, F., Gritsenko, V., Lu, H., Zhen, C., Gao, L., Berman, J., & Jiang, Y.-Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00723-21 · Cited by 49
“H99 was streaked from 280°C stock onto YPD agar as described previously (27).”
BackgroundMethodSelf-citationGerstein, A. C., & Berman, J. (2020) · mSphere · doi:10.1128/msphere.00480-20 · Cited by 44
“In many other cases, more than one gene may contribute to the phenotype (22, 27, 48, 68, 69).”
Self-citationGenetic variation in aneuploidy prevalence and tolerance across Saccharomyces cerevisiae lineages
Scopel, E. F. C., Hose, J., Bensasson, D., & Gasch, A. P. (2021) · Genetics · doi:10.1093/genetics/iyab015 · Cited by 46
Mba, I. E., Nweze, E. I., Eze, E. A., & Anyaegbunam, Z. K. G. (2022) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2022.105256 · Cited by 46
The Role of Structural Variation in Adaptation and Evolution of Yeast and Other Fungi
Gorkovskiy, A., & Verstrepen, K. J. (2021) · Genes · doi:10.3390/genes12050699 · Cited by 47
Candida glabrata: A powerhouse of resistance
Duggan, S., & Usher, J. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011651 · Cited by 47
“albicans upon exposure to antifungal and anticancer drugs (Fig 1) [5].”
BackgroundBeyond resistance: antifungal heteroresistance and antifungal tolerance in fungal pathogens
Yang, F., & Berman, J. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102439 · Cited by 42
Self-citationZhang, Z., Bendixsen, D. P., Janzen, T., Nolte, A. W., Greig, D., & Stelkens, R. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz211 · Cited by 42
Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome
Sephton-Clark, P., Tenor, J. L., Toffaletti, D. L., Meyers, N., Giamberardino, C. D., Molloy, S. F., Palmucci, J. R., Chan, A. K., Chikaonda, T., Heyderman, R. S., et al. (2022) · mBio · doi:10.1128/mbio.02626-22 · Cited by 42
“Aneuploidy has been linked to broad-spectrum stress resistance in Candida species (63), and in C.”
BackgroundFeng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Cancer Cell Fusion and Post-Hybrid Selection Process (PHSP)
Hass, R., von der Ohe, J., & Dittmar, T. (2021) · Cancers · doi:10.3390/cancers13184636 · Cited by 40
“Moreover, aneuploidy-driven adaptation processes to the anticancer drug hydroxyurea were correlated to a cross-adaptation to the first-line antifungal compound caspofungin, which was attributed to a chromosomal trisomy [73].”
BackgroundChromatin-Mediated Regulation of Genome Plasticity in Human Fungal Pathogens
Buscaino, A. (2019) · Genes · doi:10.3390/genes10110855 · Cited by 40
Life in plastic, it’s fantastic! How Leishmania exploit genome instability to shape gene expression
Black, J. A., Reis-Cunha, J. L., Cruz, Â. K., & Tosi, L. R. O. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1102462 · Cited by 40
“For a host, a genetically flexible pathogen has important clinical consequences, including the selection and emergence of drug resistance, ultimately limiting treatment options (Yang et al., 2019; Sah et al., 2021; Kukurudz et al., 2022).”
BackgroundMultifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans
Xu, Y., Lu, H., Zhu, S., Li, W.-Q., Jiang, Y.-Y., Berman, J., & Yang, F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00321-21 · Cited by 35
“Gene deletions were performed as described previously (54).”
MethodSelf-citationNarayanan, A., Kumar, P., Chauhan, A., Kumar, M., Yadav, K., Banerjee, A., Sharma, R. D., Rudramurthy, S. M., Chakrabarti, A., Sanyal, K., et al. (2022) · mBio · doi:10.1128/mbio.03052-22 · Cited by 35
“sistance to hydroxyurea as well as caspofungin (17).”
BackgroundKukurudz, R. J., Chapel, M., Wonitowy, Q., Adamu Bukari, A.-R., Sidney, B., Sierhuis, R., & Gerstein, A. C. (2022) · G3 · doi:10.1093/g3journal/jkac156 · Cited by 35
On the role of p53 in the cellular response to aneuploidy
Narkar, A., Johnson, B. A., Bharne, P., Zhu, J., Padmanaban, V., Biswas, D., Fraser, A. K., Iglesias, P. A., Ewald, A. J., & Li, R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108892 · Cited by 34
Patterns and mechanisms of fungal genome plasticity
Sauters, T. J. C., & Rokas, A. (2025) · Current Biology · doi:10.1016/j.cub.2025.04.003 · Cited by 35
The adaptive roles of aneuploidy and polyclonality in Leishmania in response to environmental stress
Negreira, G. H., de Groote, R., Giel, D. V., Monsieurs, P., Maes, I., Muylder, G. D., den Broeck, F. V., Dujardin, J., & Domagalska, M. A. (2023) · EMBO Reports · doi:10.15252/embr.202357413 · Cited by 36
“:3) umov (cid:1) a et al , 2016; Yang et al , 2021), with specific aneuploidy changes being able to confer resistance against environmental stresses such as drug pressure (Yang et al , 2019).”
Using genomics to understand the mechanisms of virulence and drug resistance in fungal pathogens
Schikora-Tamarit, M. À., & Gabaldón, T. (2022) · Biochemical Society Transactions · doi:10.1042/bst20211123 · Cited by 35
The role of gene copy number variation in antimicrobial resistance in human fungal pathogens
Jay, A., Jordan, D., Gerstein, A. C., & Landry, C. R. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00072-1 · Cited by 30
Short-term evolution strategies for host adaptation and drug escape in human fungal pathogens
Beekman, C. N., & Ene, I. V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008519 · Cited by 30
“albicans, formation of different isochromosomes (partial duplication, i(4R) [17] and i(5L) [9]) enabled azole resistance, while trisomy of chromosome 2 conferred caspofungin resistance [18].”
BackgroundAneuploidy Underlies Tolerance and Cross-Tolerance to Drugs in Candida parapsilosis
Yang, F., Lu, H., Wu, H., Fang, T., Berman, J., & Jiang, Y.-Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00508-21 · Cited by 27
Self-citationGervais, N. C., Bella, A. A. L., Wensing, L. F., Sharma, J., Acquaviva, V., Best, M. A., López, R. O. C., Fogal, M., Uthayakumar, D., Chavez, A., et al. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac301 · Cited by 31
Sah, S. K., Hayes, J. J., & Rustchenko, E. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009564 · Cited by 26
“albicans cells to chemotherapeutic drug hydroxyurea results in an Hu phenotype due to Ch2 trisomy, similarly to exposure to caspofungin [22], the effect, which might contribute to development of Candida infection in chemotherapy-treated patient [28].”
BackgroundAvramovska, O., & Hickman, M. A. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400752 · Cited by 28
Aneuploidy enables cross-tolerance to unrelated antifungal drugs in Candida parapsilosis
Sun, L.-L., Li, H., Yan, T., Cao, Y., Jiang, Y., & Yang, F. J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1137083 · Cited by 25
“auris, and Cryptococcus neoformans, drug-tolerant aneuploids spontaneously revert to euploids in the absence of a drug, and tolerance to drugs is concomitantly lost (Sionov et al., 2010; Yang et al., 2019; Bing et al., 2020).”
BackgroundSelf-citationGenomic Variation-Mediating Fluconazole Resistance in Yeast
Wang, W., Cai, H., Qu, S.-Y., Lin, W., Liang, C., Liu, H., Xie, Z., & Yuan, Y. (2022) · Biomolecules · doi:10.3390/biom12060845 · Cited by 22
“The cr ss- t ti cc r because alleles of two adaptor genes are located on the same chromosome [20].”
BackgroundInfluentialAneuploidy Mediates Rapid Adaptation to a Subinhibitory Amount of Fluconazole in Candida albicans
Sun, L.-L., Li, H., Yan, T.-H., Fang, T., Wu, H., Cao, Y.-B., Lu, H., Jiang, Y.-Y., & Yang, F. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03016-22 · Cited by 17
“In the absence of stress, aneuploids spontaneously and rapidly revert to euploidy (23, 24).”
BackgroundSelf-citationInsight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020143 · Cited by 18
“C. albicans ’ heteroresistance to echinocandins is related to chr2, as chr2 trisomy can be induced after exposure to caspofungin [132].”
Candida auris : host interactions, antifungal drug resistance, and diagnostics
Chowdhary, A., Lionakis, M. S., & Chauhan, N. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00187-22 · Cited by 22
“In addition, aneuploidy, specifically monosomy of chromosome 5 and trisomy of chromosome 2, is associated with echinocandin resistance in C. albicans (232, 233).”
Tetraploidy accelerates adaptation under drug selection in a fungal pathogen
Avramovska, O., Smith, A. C., Rego, E., & Hickman, M. A. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.984377 · Cited by 18
Ksiezopolska, E., Schikora-Tamarit, M. À., Carlos Nunez-Rodriguez, J., & Gabaldón, T. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1416509 · Cited by 15
“…shown that gene copy number variations, including whole-chromosome (Chr) aneuploidies, may contribute to antifungal drug resistance (Coste et al., 2006; Selmecki et al., 2006; Sasse et al., 2012; Yang et al., 2013; Anderson et al., 2017; Yang et al., 2017; Todd et al., 2019; Yang et al., 2019).”
Ma, Q., Ola, M., Iracane, E., & Butler, G. (2019) · mSphere · doi:10.1128/msphere.00402-19 · Cited by 16
“In addition, trisomy of chromosome 2 is associated with cross-adaptation to multiple drugs, including hydroxyurea and caspofungin (12).”
BackgroundAneuploidy Underlies Brefeldin A‐Induced Antifungal Drug Resistance in Cryptococcus Neoformans
Zhang, Z.-H., Sun, L.-L., Fu, B.-Q., Deng, J., Jia, C.-L., Miao, M.-X., Yang, F., Cao, Y.-B., & Yan, T.-H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1397724 · Cited by 14
Self-citationCarroll, C., Manaprasertsak, A., Castro, A. B., van den Bos, H., Spierings, D. C. J., Wardenaar, R., Bukkuri, A., Engström, N., Baratchart, E., Yang, M., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0396 · Cited by 15
Zheng, L., Xu, Y., Wang, C., & Guo, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1450557 · Cited by 14
“Different stresses may select for the same aneuploidy, leading to cross-tolerance to unrelated stresses (Yang et al., 2019, 2021b).”
BackgroundEvolution and strain diversity advance exploration of Candida albicans biology
Anderson, M. Z., & Dietz, S. M. (2024) · mSphere · doi:10.1128/msphere.00641-23 · Cited by 13
“Emergence of aneuploidy that confers tolerance to one antifungal drug can facilitate cross-tolerance to other compounds with similar modes of action or through the linkage of genes that mitigate other compounds (55, 56).”
BackgroundTeixeira, M. D. M., Almeida‐Paes, R., Bernardes‐Engemann, A. R., Nicola, A. M., de Macedo, P. M., do Valle, A. C. F., Gutierrez‐Galhardo, M. C., Freitas, D. F. S., Barker, B. M., Matute, D. R., et al. (2022) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2022.103743 · Cited by 15
Aneuploidy confers a unique transcriptional and phenotypic profile to Candida albicans
Mackey, A. I., Fillinger, R. J., Hendricks, P. S., Thomson, G. J., Cuomo, C. A., Bennett, R. J., & Anderson, M. Z. (2025) · Nature Communications · doi:10.1038/s41467-025-58457-3 · Cited by 11
Accessory Chromosome Contributes to Virulence of Banana Infecting Fusarium oxysporum Tropical Race 4
Dijkstra, J., van Westerhoven, A. C., Gómez-Gil, L., Aguilera-Gálvez, C., Nakasato‐Tagami, G., Garnier, S. D., Yamazaki, M., Arie, T., Kamakura, T., Arazoe, T., et al. (2025) · Molecular Plant Pathology · doi:10.1111/mpp.70146 · Cited by 11
Li, H., Cao, Y., Yan, T., Jiang, Y., & Yang, F. J. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.09.028 · Cited by 9
Self-citationZheng, L., Xu, Y., Wang, C., Dong, Y., & Guo, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1470454 · Cited by 9
Highly parallelized laboratory evolution of wine yeasts for enhanced metabolic phenotypes
Ghiaci, P., Jouhten, P., Martyushenko, N., Roca-Mesa, H., Vázquez, J., Konstantinidis, D., Stenberg, S., Andrejev, S., Grkovska, K., Mas, A., et al. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00059-0 · Cited by 8
Vydzhak, O., Bender, K., Klermund, J., Busch, A., Reimann, S., & Luke, B. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102939 · Cited by 7
Chromosome 1 trisomy confers resistance to aureobasidin A in Candida albicans
Zheng, L., Xu, Y., Dong, Y., Ma, X., Wang, C., Yang, F. J., & Guo, L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1128160 · Cited by 8
Self-citationTherapeutic Dose of Hydroxyurea-Induced Synaptic Abnormalities on the Mouse Spermatocyte
Fan, X., Zhu, Y., Wang, N., Zhang, B., Zhang, C., & Wang, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.666339 · Cited by 7
“Additionally, these accumulations of DNA damage or chromosome fragility under replication stress by chemical agents frequently presented chromosomal abnormalities (Garcia-Cruz et al., 2009; Passerini et al., 2016; Yang et al., 2019).”
BackgroundAneuploidy enables adaptation to brefeldin A in Candida albicans
Wang, W., Wang, C., Dong, Y., Yang, F. J., & Xu, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1562726 · Cited by 7
Self-citationWei, Y., Wang, J., Tang, N., Lin, Z., Li, W., Xu, Y., & Guo, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1618815 · Cited by 7
“…genomic plasticity, often employing chromosomal aneuploidy to rapidly adapt to antifungal stress (Selmecki et al., 2006; Yang et al., 2013, Yang et al., 2017, Yang et al., 2019; Li et al., 2022; Sun et al., 2023; Yang et al., 2023; Zheng et al., 2023; Guo et al., 2024; Zheng et al., 2024).”
Diagnostics for human pathogenic fungal infections: Current status and future prospects
Huang, X., Moses, M., Nie, L., Wandera, E. A., & Chen, C. (2026) · hLife · doi:10.1016/j.hlife.2025.11.005 · Cited by 5
“…(LOH), aneuploidy, changes in whole chromosome copy number, genome rear-rangements, and horizontal gene transfer can lead to the over-expression or mutation of ERG11 , AFR1 , cyp51A , and TAC1 , enabling fungal pathogens to develop tolerance azole and echi-nocandin therapies [159–163].”
Druseikis, M. E., Mottola, A., & Berman, J. G. (2023) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00189-3 · Cited by 6
Self-citationWhy do certain cancer cells alter functionality and fuse?
Dittmar, T., Sieler, M., & Hass, R. (2023) · Biological Chemistry · doi:10.1515/hsz-2023-0162 · Cited by 5
Scott, N. E., Zhou, X., Wash, E., Zajac, C., Kline, S. E., Erayil, S. E., & Selmecki, A. M. (2026) · Microbial Genomics · doi:10.1099/mgen.0.001659 · Cited by 5
Fungal plasticity drives adaptation and survival across pathogenic and free-living contexts
Gebreyesus, T. G. (2026) · Discover Life · doi:10.1007/s11084-026-09731-x · Cited by 4
Day, A. W., & Kumamoto, C. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298724 · Cited by 4
“albicans with 392 pre-exposure to chemotherapeutic drugs leading to decreased caspofungin susceptibility [58].”
Induction of Antifungal Tolerance Reveals Genetic and Phenotypic Changes in Candida glabrata
Chedraoui, C., Fattouh, N., Hachem, S. E., Younes, M., & Khalaf, R. A. (2025) · Journal of Fungi · doi:10.3390/jof11040284 · Cited by 5
“An example of chromosomal abnormality leading to antifungal tolerance in C. albicans is trisomy of chromosome 2 conferring caspofungin tolerance [20,21].”
Vossen, M. L., Alhosawi, H. M., Aney, K. J., & Burrack, L. S. (2019) · Genes · doi:10.3390/genes10121013 · Cited by 4
“albicans, aneuploid cells with an isochromosome—two extra copies of 5L—have fluconazole resistance, and other specific aneuploid chromosomes can provide cross-resistance to multiple chemotherapeutic and antifungal drugs [2,3].”
BackgroundIsogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations
Winnard, P. T., Morsberger, L. A., Yonescu, R., Jiang, L., Zou, Y. S., & Raman, V. (2023) · Cancers · doi:10.3390/cancers15051420 · Cited by 4
“Cytogenomic studies in clinical settings have consistently demonstrated that copy number variations, ploidy, chromosomal aberrations, and heterogeneity are very often independent prognostic markers of survival and resistance to chemotherapies [4,25,28,30,55,56].”
BackgroundMontoya, M. C., Wilhoit, K., Murray, D., Perfect, J. R., & Magwene, P. M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116103 · Cited by 3
Morshneva, A. V., Gnedina, O. O., Fedotova, K., Yartseva, N. M., Aksenov, N., & Igotti, M. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188869 · Cited by 3
“Chromosomal instability has been associated with the acquisition of drug resistance [10–12].”
Fleres, G., Cheng, S., Badrane, H., Dupont, C. L., Espinoza, J. L., Abbey, D., Driscoll, E., Newbrough, A., Hao, B., Mansour, A., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf495 · Cited by 3
Lipid-Based Drug Delivery Systems as Emerging Tools to Overcome Antifungal Resistance
Arana, L., Guridi, A., Sevillano, E., Tamayo, E. H., Eraso, E., Alkorta, I., & Maté, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104487 · Cited by 2
“Beyond genetic mutations, genomic plasticity (e.g., chromosome 2 trisomy in C. albicans ) may confer tolerance, and ERG3 mutations in N. glabratus and C. auris can generate cross-resistance to fluconazole [61,62].”
Fleres, G., Cheng, S., Badrane, H., Dupont, C. L., Espinoza, J. L., Abbey, D., Driscoll, E., Newbrough, A., Hao, B., Mansour, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.16.618724 · Cited by 2
Li, S., Li, B., & Guo, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168786 · Cited by 1
Cytrynbaum, E. G., & McClean, M. N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115740 · Cited by 1
Xu, Y., & Yang, F. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.07.031112
“genes on chromosome 2 and different pathways (15).”
BackgroundSelf-citationIppolito, M. R., & Santaguida, S. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.10.012
The CRISPR Toolbox in Medical Mycology: State of the Art and Perspectives
Morio, F., Lombardi, L., & Butler, G. (2023) · doi:10.1201/9781003298038-38
Multi-drug tolerance in Leishmania persister-like cells
Aroni-Soto, A., Monsieurs, P., Goovaerts, O., Choukri, K., Khanal, B., Adriaensen, W. J., Dujardin, J., Barrett, M. P., & Domagalska, M. A. (2026) · Communications Biology · doi:10.1038/s42003-026-10456-w
“Cross-toleranceto severalantifungalcompoundshasbeenobservedinpathogenicfungiand waslinkedtochangesinaneuploidypatternsandnotthepersisterstate 46,47 .”
Antifungal resistance: from classical mechanisms to the expanding role of acetyltransferases
Werneck, S. M. C., Gouveia‐Eufrásio, L., de Freitas, G. J. C., de Carvalho, D. S., César, I. C., Rossato, L. L., Bastos, R. W., Peres, N. T. A., & Santos, D. A. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01273-8
“Exposure of C. albicans to hydroxyurea or tunicamycin selects for chromosome 2 trisomy, a genomic alteration related to increased tolerance to caspofungin [107, 108].”
Harnessing Burkholderia cepacia complex for sustainable agriculture
Kousar, A. (2026) · Ghent University Academic Bibliography (Ghent University)
Patiño, L. H., Muñoz, M. A. M., Ramírez, A. L., Jiménez-A, M. J., Ceballos-Garzón, A., Parra‐Giraldo, C. M., & Ramírez, J. D. (2026) · Acta Tropica · doi:10.1016/j.actatropica.2026.108235
Metadata
- Authors
- Yang, F., Teoh, F., Tan, A. S. M., Cao, Y., Pavelka, N., & Berman, J.
- Affiliations
- Tel Aviv University (IL)
- Agency for Science, Technology and Research (SG)
- Shanghai University of Traditional Chinese Medicine (CN)
- Corresponding author
- Pavelka, Norman
- Berman, Judith
- Venue
- Molecular Biology and Evolution
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-27
- Volume
- 36
- Issue
- 8
- Pages
- 1768-1782
- ISSN
- 0737-4038 (ISSN-L)
- 1537-1719
- PMC
- PMC6657732
- OpenAlex
- W2940793950
- Cited by
- 101
- References
- 91
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 13 · 2023: 15 · 2022: 15 · 2021: 17 · 2020: 13 · 2019: 6
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Biology and Evolution (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Research Council (340087)
- Agency for Science, Technology and Research (JCO/1437a00117)
- Singapore Immunology Network
- National Science Foundation of China (81872910)
- A*STAR Graduate Scholarship
- PBC China-Israel Postdoctoral Fellowship Program
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- aneuploidy, cross-adaptation, Candida albicans, drug tolerance, antifungal resistance, chemoresistance, hydroxyurea, caspofungin, fluconazole, trisomy, monosomy, chromosome 2, chromosome 5, stress response pathways, systemic candidiasis, fungal pathogens
- MeSH terms
- Caspofungin, Adaptation, Biological, Aneuploidy, Animals, Antifungal Agents, Antineoplastic Agents, Candida albicans, Hydroxyurea, Chromosomes, Fungal, Calcineurin, Drug Resistance, Fungal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.